This proposal is designed to develop new methods using dendritic cells (DC) to induce allotolerance in a mouse model. The proposal is based on the observation that i.v. infused thymic DCs selectively home to thymus and induce alloantigenic tolerance as compared to splenic DCs that show impaired thymic homing capabilities and do not have the ability to induced tolerance. These data are corroborated by the ability of thymic DCs to selectively home in the thymus after adoptive transfer leading to tolerance. The overall goals of this proposal are to 1) understand the mechanism(s) of the tolerance induced by allogeneic DCs, 2) define the DC subpopulation with the highest tolerogenic capability, and 3) develop the technical methodologies designed to optimize the use of adoptive transfer of DCs to induce allotolerance. The focus of this proposal is to further develop methodologies that will render DC tolerogen therapies clinically feasible. In particular, they propose to fully delineate mechanisms of effects in this system, improve methods for identification and isolation of DC with therapeutic potential, increase the duration of tolerance, explore the phenotypes necessary for unique thymic homing, and develop in vitro techniques to propagate or immortalize these cells. In addition to basic implications, they propose that their findings may ultimately have significant clinical applications, with considerable practical advantages over other methods for intrathymic introduction of neo-antigens to obviate allograft rejection and other T-cell-mediated disease processes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL064192-01
Application #
6041490
Study Section
Lung Biology and Pathology Study Section (LBPA)
Project Start
2000-08-15
Project End
2001-04-30
Budget Start
2000-08-15
Budget End
2001-04-30
Support Year
1
Fiscal Year
2000
Total Cost
$299,064
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Studer, Sean M; George, M Patricia; Zhu, Xuehai et al. (2008) CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients. Am J Respir Crit Care Med 178:765-73
Feghali-Bostwick, Carol A; Tsai, Christopher G; Valentine, Vincent G et al. (2007) Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis. J Immunol 179:2592-9
Johnson, Bruce A; Iacono, Aldo T; Zeevi, Adriana et al. (2003) Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med 167:1271-8
Duncan, Steven R; Leonard, Colm; Theodore, James et al. (2002) Oligoclonal CD4(+) T cell expansions in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med 165:1439-44
Duncan, Steven R; Capetanakis, Nickolas G; Lawson, Brian R et al. (2002) Thymic dendritic cells traffic to thymi of allogeneic recipients and prolong graft survival. J Clin Invest 109:755-64